-
Diversifying Supply Chains — Does USMCA Offer New Opportunities for Pharma?
cphi-online
August 09, 2021
Dependence on Asia – and specifically China – has been the subject of a great deal of attention by political and industry leaders in the last year. In North America, this has led to calls to “reshore” drug production to domestic facilities.
-
UK announces £20 million investment into medicine manufacturing
europeanpharmaceuticalreview
December 01, 2020
UK Prime Minister Boris Johnson has announced a £20 million investment fund for medicine manufacturing and supply chains in the UK.
-
Global pharma’s two battles – supply continuity and COVID-19 vaccine
expresspharma
September 23, 2020
Richa Mahindru, Domain Leader, Pharma and Life Sciences Practice, Praxis Global Alliance and Ishani Jain, Member, Pharma and Life Sciences Practice, Praxis Global Alliance elaborate on how pharma companies are dealing with these twin challenges and ...
-
Preparedness of pharma supply chains to manage the production of COVID-19 therapies
biospectrumasia
August 22, 2020
The rise in chronic diseases and the need for secondary devices over the last ten years has driven demand for more advanced and customized packaging solutions.
-
Asia set to lead the way on healthcare but supply chains face complex challenges
biospectrumasia
March 18, 2019
New biopharma, medical advances and innovative healthcare products largely evolved in developed parts of the world before making their way to emerging markets.
-
Supply chains key to Life Sciences transformation, says new report
europeanpharmaceuticalreview
July 10, 2017
Life Sciences and Healthcare supply chains need transformation to support the increasing cost pressures and consumer demands for new and more convenient, affordable care models…